Interferon-γ capture T cell therapy for persistent Adenoviraemia following allogeneic haematopoietic stem cell transplantation

British Journal of Haematology

Volumn 161, Issue 3, 2013, Pages 449-452

  Qasim, Waseem ^a   Gilmour, Kimberly ^a   Zhan, Hong ^a   Derniame, Sophie ^a   Mcnicol, Anne Marie ^a   Ip, Winnie ^a   Hiwarkar, Prashant ^a   Veys, Paul ^b   Gaspar, Hubert B ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Lymphocytes; Transplantation; Viruses

Indexed keywords

ALEMTUZUMAB; CIDOFOVIR; CYCLOSPORIN; FLUDARABINE; GAMMA INTERFERON; MELPHALAN; PREDNISOLONE; RIBAVIRIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADENOVIRUS INFECTION; ADOPTIVE TRANSFER; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANALYTICAL EQUIPMENT; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CELL SEPARATION; CELLULAR IMMUNITY; CYTOKINE RELEASE; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; RISK REDUCTION; SKIN DISEASE; T CELL DEPLETION; T LYMPHOCYTE; VIRAL CLEARANCE; VIRUS LOAD; VIRUS REACTIVATION;

ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; ADOLESCENT; ANTIGENS, VIRAL; ANTIVIRAL AGENTS; CAPSID PROTEINS; CHILD; CHROMATOGRAPHY, LIQUID; COMBINED MODALITY THERAPY; CYTOSINE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOMAGNETIC SEPARATION; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY, ADOPTIVE; INFANT; INFANT, NEWBORN; INTERFERON-GAMMA; LYMPHOCYTE TRANSFUSION; ORGANOPHOSPHONATES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECEPTORS, INTERFERON; RIBAVIRIN; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTE SUBSETS; TRANSPLANTATION, HOMOLOGOUS; VIREMIA;

EID: 84876179209     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12251     Document Type: Article

References (10)

1. Chatziandreou, I., Gilmour, K.C., McNicol, A.M., Costabile, M., Sinclair, J., Cubitt, D., Campbell, J.D., Kinnon, C., Qasim, W. & Gaspar, H.B. (2007) Capture and generation of adenovirus specific T cells for adoptive immunotherapy. British journal of haematology, 136, 117-126.
2. Comoli, P., Schilham, M.W., Basso, S., van, V.T., Bernardo, M.E., Maccario, R., van Tol, M.J., Locatelli, F. & Veltrop-Duits, L.A. (2008) T-cell lines specific for peptides of adenovirus hexon protein and devoid of alloreactivity against recipient cells can be obtained from HLA-haploidentical donors. Journal of immunotherapy, 31, 529-536.
3. Feuchtinger, T., Matthes-Martin, S., Richard, C., Lion, T., Fuhrer, M., Hamprecht, K., Handgretinger, R., Peters, C., Schuster, F.R., Beck, R., Schumm, M., Lotfi, R., Jahn, G. & Lang, P. (2006) Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. British journal of haematology, 134, 64-76.
4. Hiwarkar, P., Gaspar, H.B., Gilmour, K., Jagani, M., Chiesa, R., Bennett-Rees, N., Breuer, J., Rao, K., Cale, C., Goulden, N., Davies, G., Amrolia, P., Veys, P. & Qasim, W. (2012) Impact of viral reactivations in the era of pre-emptive antiviral drug therapy following allogeneic haematopoietic SCT in paediatric recipients. Bone Marrow Transplantation, doi: 10.1038/bmt.2012.221.
5. Kampmann, B., Cubitt, D., Walls, T., Naik, P., Depala, M., Samarasinghe, S., Robson, D., Hassan, A., Rao, K., Gaspar, H., Davies, G., Jones, A., Cale, C., Gilmour, K., Real, M., Foo, M., Bennett-Rees, N., Hewitt, A., Amrolia, P. & Veys, P. (2005) Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. British journal of haematology, 130, 595-603.
6. Leen, A.M., Christin, A., Myers, G.D., Liu, H., Cruz, C.R., Hanley, P.J., Kennedy-Nasser, A.A., Leung, K.S., Gee, A.P., Krance, R.A., Brenner, M.K., Heslop, H.E., Rooney, C.M. & Bollard, C.M. (2009) Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation. Blood, 114, 4283-4292.
7. Lindemans, C.A., Leen, A.M. & Boelens, J.J. (2010) How I treat adenovirus in hematopoietic stem cell transplant recipients. Blood, 116, 5476-5485.
8. Lion, T., Baumgartinger, R., Watzinger, F., Matthes-Martin, S., Suda, M., Preuner, S., Futterknecht, B., Lawitschka, A., Peters, C., Potschger, U. & Gadner, H. (2003) Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood, 102, 1114-1120.
9. Peggs, K.S., Thomson, K., Samuel, E., Dyer, G., Armoogum, J., Chakraverty, R., Pang, K., Mackinnon, S. & Lowdell, M.W. (2011) Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation. Clinical infectious diseases, 52, 49-57.
10. Qasim, W., Derniame, S., Gilmour, K., Chiesa, R., Weber, M., Adams, S., Rao, K., Amrolia, P., Goulden, N., Veys, P. & Gaspar, H. (2011) Third-party virus-specific T cells eradicate adenoviraemia but trigger bystander graft-versus-host disease. British journal of haematology, 154, 150-153.